Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125224542 | 12522454 | 2 | F | 1998 | 20160721 | 20160701 | 20160728 | EXP | US-BAUSCH-BL-2016-014813 | BAUSCH AND LOMB | 0.00 | F | Y | 0.00000 | 20160728 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125224542 | 12522454 | 1 | PS | ATIVAN | LORAZEPAM | 1 | Oral | 17794 | 1 | MG | TABLET | QID | |||||||
| 125224542 | 12522454 | 2 | C | CARISOPRODOL. | CARISOPRODOL | 1 | Oral | 0 | 350 | MG | QD | ||||||||
| 125224542 | 12522454 | 3 | C | XARELTO | RIVAROXABAN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 125224542 | 12522454 | 4 | C | DEXILANT | DEXLANSOPRAZOLE | 1 | Oral | 0 | |||||||||||
| 125224542 | 12522454 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 125224542 | 12522454 | 6 | C | FLECAINIDE | FLECAINIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 125224542 | 12522454 | 7 | C | L-THYROXINE | LEVOTHYROXINE | 1 | Oral | 0 | 50 | MG | QD | ||||||||
| 125224542 | 12522454 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 125224542 | 12522454 | 9 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 125224542 | 12522454 | 10 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125224542 | 12522454 | 1 | Anxiety |
| 125224542 | 12522454 | 2 | Abdominal distension |
| 125224542 | 12522454 | 3 | Product used for unknown indication |
| 125224542 | 12522454 | 4 | Product used for unknown indication |
| 125224542 | 12522454 | 5 | Blood cholesterol abnormal |
| 125224542 | 12522454 | 6 | Arrhythmia |
| 125224542 | 12522454 | 7 | Thyroid disorder |
| 125224542 | 12522454 | 8 | Blood pressure abnormal |
| 125224542 | 12522454 | 9 | Dyspnoea |
| 125224542 | 12522454 | 10 | Hypersensitivity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125224542 | 12522454 | OT |
| 125224542 | 12522454 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125224542 | 12522454 | Cognitive disorder | |
| 125224542 | 12522454 | Drug ineffective | |
| 125224542 | 12522454 | Loss of consciousness | |
| 125224542 | 12522454 | Memory impairment | |
| 125224542 | 12522454 | Pneumonia | |
| 125224542 | 12522454 | Product quality issue | |
| 125224542 | 12522454 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125224542 | 12522454 | 1 | 1974 | 0 |